OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
38 hedge funds and large institutions have $25.6M invested in OncoSec Medical Incorporated in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 8 closing their positions.
650% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 2
251% more capital invested
Capital invested by funds: $7.3M → $25.6M (+$18.3M)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
12% more funds holding
Funds holding: 34 → 38 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$7.47M |
| 2 |
NC
Nexthera Capital
New York
|
+$3.85M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.11M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.93M |
| 5 |
Millennium Management
New York
|
+$1.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLCM
Crawford Lake Capital Management
Lakewood,
New Jersey
|
-$482K |
| 2 |
Renaissance Technologies
New York
|
-$272K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$261K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$249K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$163K |
ONCS Hedge Fund Activity: Q1 2018 in Review
38 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2018, worth a combined $25.6M — up 251% from $7.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ONCS positions and 8 closed out — a net gain of 4 holders — while 15 added to existing stakes and 2 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $7.47M. The largest seller was Crawford Lake Capital Management, exiting entirely with an estimated $482K sold.
- 38 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2018, up from 34 in Q4 2017.
- Funds reported $25.6M of OncoSec Medical Incorporated stock for Q1 2018, up 251% quarter-over-quarter.
- 12 funds opened new OncoSec Medical Incorporated positions in Q1 2018 and 8 closed out, a net change of +4 holders.
- The largest OncoSec Medical Incorporated buyer in Q1 2018 was Avoro Capital Advisors, an estimated $7.47M added.
- The largest OncoSec Medical Incorporated seller in Q1 2018 was Crawford Lake Capital Management, an estimated $482K sold.
Based on aggregated 13F filings for Q1 2018.